Package 0363-1320-23

Brand: acetaminophen 250mg aspirin 250mg caffeine 65mg

Generic: acetaminophen 250mg aspirin 250mg caffeine 65mg
NDC Package

Package Facts

Identity

Package NDC 0363-1320-23
Digits Only 0363132023
Product NDC 0363-1320
Description

20 TABLET in 1 BOTTLE (0363-1320-23)

Marketing

Marketing Status
Marketed Since 2019-09-24
Brand acetaminophen 250mg aspirin 250mg caffeine 65mg
Generic acetaminophen 250mg aspirin 250mg caffeine 65mg
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "cbd064bd-32f1-4561-9b74-e0058a27d59a", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["98bb28ed-d146-ca3d-e053-2a95a90a9eaf"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["WALGREENS CO."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (0363-1320-12)", "package_ndc": "0363-1320-12", "marketing_start_date": "20190924"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (0363-1320-23)", "package_ndc": "0363-1320-23", "marketing_start_date": "20190924"}, {"sample": false, "description": "80 TABLET in 1 BOTTLE (0363-1320-80)", "package_ndc": "0363-1320-80", "marketing_start_date": "20190924"}], "brand_name": "Acetaminophen 250mg Aspirin 250mg Caffeine 65mg", "product_id": "0363-1320_cbd064bd-32f1-4561-9b74-e0058a27d59a", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "0363-1320", "generic_name": "Acetaminophen 250mg Aspirin 250mg Caffeine 65mg", "labeler_name": "WALGREENS CO.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Acetaminophen 250mg Aspirin 250mg Caffeine 65mg", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190924", "listing_expiration_date": "20261231"}